Comprendre les gouttes de champignons : comment elles affectent le cerveau

What are shroom drops?

Shroom drops are liquid preparations that contain compounds that interact with serotonin systems in the brain. These compounds can be naturally occurring, such as psilocybin found in certain mushrooms, or structurally related analogues that are discussed in modern research contexts. Once in the body, these compounds influence serotonin receptors, which play a role in mood, perception and thinking.

Liquid formats, like Amsterdam Drops, allow for precise measurements, which are often preferred in research settings for maintaining consistent conditions in controlled studies.

How these compounds interact with the brain

Psilocybin-related compounds mainly interact with serotonin receptors in the brain. These systems help regulate how we perceive the world, process information and think. Brain imaging has shown that psilocybin can temporarily alter the communication between different brain regions, allowing the brain to operate in a more flexible way. This shift may lead to enhanced creativity or a sense of interconnectedness, depending on the individual.

How modern shroom drops differ from traditional compounds

There are important differences between traditional shroom preparations and more recent liquid formulations. These differences relate to how the compounds behave in the body, how they are processed and how they are discussed in research contexts.

Traditional shroom preparations are typically associated with psilocybin, a compound that is converted into psilocin in the body. This conversion process plays a role in how the effects develop over time. However, psilocybin in isolated or processed form is subject to strict regulations in many countries.

Directly active analogues and their effects

Some modern liquid formulations use compounds that are structurally related to psilocin, often referred to as analogues. Examples include substances such as 4-HO-MET and 4-PR-MET, which are designed to interact more directly with serotonin receptors without requiring the same conversion process. Because these compounds are already active in their administered form, differences in onset and physical experience are sometimes discussed, such as a more direct onset or a different physical response, although individual experiences may vary and research is still developing.

Changes in brain communication

One key area affected by psilocybin is the Default Mode Network (DMN), which is active when we reflect on ourselves or think about memories. Psilocybin can reduce activity in the DMN, allowing for greater communication between other regions of the brain. This can help the brain break free from habitual thought patterns, allowing new connections to form and enhancing cognitive flexibility.

Neuroplasticity and brain adaptation

Neuroplasticity refers to the brain’s ability to form new connections between neurons. Some laboratory studies suggest that psilocybin may promote neuroplasticity, encouraging the growth of new neural pathways. Although these findings are promising, most research is still in early stages, and long-term effects are still being explored. Microdosing of psilocybin, especially through drops like Amsterdam Drops (Super Strong), is also being studied for its potential impact on cognitive enhancement over time, although placebo effects are a consideration in some studies.

Different formulations and how they are used

Within this category, different formulations can be developed depending on the intended use and concentration. While the underlying interaction with serotonin systems remains similar, variations in compound type and dosage can influence how these products are discussed and applied in research contexts.

For example, formulations based on compounds such as 4-HO-MET are already widely discussed, while newer variations using 4-PR-MET are also emerging. An example of this are our Berlin Drops, which are based on this newer type of compound. These formulations may be offered in different strengths, ranging from regular concentrations to more potent versions, as well as lower-dose formats that are explored in the context of microdosing. These variations allow for more controlled experimentation with dosage and timing, although research into these formulations is still developing and outcomes can vary based on context and expectations.

Thinking, perception and emotional processing

Research often looks at how psilocybin affects thinking, perception and emotional processing. These compounds can enhance associative thinking and help individuals process sensory information differently. By examining brain communication patterns, scientists are gaining a better understanding of how psychedelic substances influence thought processes and emotional responses.

Research conditions and safety rules

The legal status of psilocybin and related compounds varies between countries. Modern research is conducted under strict ethical guidelines and controlled conditions, ensuring the safety of participants. Studies typically involve screening procedures and careful monitoring to ensure reliable results. This is why it’s important to distinguish between research settings and unsupervised use when discussing these compounds.

Shroom drops in modern research discussions

Current discussions around these compounds focus on how they affect serotonin systems and alter brain communication. Carefully prepared formulations help maintain consistent conditions in experimental settings, enabling researchers to compare results across different studies. These drops offer a precise and controlled way to administer compounds that interact with similar biological pathways.